MANAGEMENT OF SLOW COLONIC TRANSIT CONSTIPATION IN PARKINSON’S DISEASE: CURRENT EVIDENCE AND A COMMUNITY PHARMACY PERSPECTIVE
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2016, Vol 8, Issue 7
Abstract
The non-motor symptoms of Parkinson's disease are often under-recognised and undertreated. Constipation is exceedingly common in Parkinson's disease, reportedly affecting up to 70% of patients. Pharmacists are ideally positioned to screen patients with Parkinson's disease for constipation and to optimise constipation management. This review will describe the evidence base for the use of different treatments in the management of constipation in patients with Parkinson's disease. PubMed, Embase and Web of Science were searched using the following search terms: "constipation" OR "gastrointestinal dysfunction" OR "slow colonic transit" OR "defecatory dysfunction" OR "slow motility" AND "treatment" OR "management" OR "therapy" AND "Parkinson* disease". The literature indicates macrogol is a safe and effective treatment for constipation in Parkinson’s disease; it should be considered a first line treatment and can be recommended by the pharmacist over-the-counter. Pharmacists can provide information regarding fibre supplementation with psyllium, which may be effective and can be initiated early. Lubiprostone appears to be a promising option, but larger and longer trials are warranted. Although many commonly employed treatments for constipation have not been evaluated for efficacy in Parkinson's disease, pharmacists can utilise available data to make evidence-based recommendations to optimise management of constipation and improve patient quality of life.Keywords: Constipation, Parkinson’s disease, Treatment, Non-motor, Pharmacy practice
Authors and Affiliations
Michaela E Johnson, Jacinta L. Johnson
Keywords
Related Articles
- EP ID EP576205
- DOI -
- Views 92
- Downloads 0
EFFECT OF VITAMIN C ON mRNA EXPRESSION OF BMPs DURING FRACTURE HEALING IN THE FEMUR CALLUS OF SPRAGUE-DAWLEY FEMALE RATS
Fracture reparation is a complex physiological process. During fracture healing no scar is left but a new bone tissue is created. In addition to mechanical stabilization, inflammatory cytokines, growth factors, vitamins...
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF METOPROLOL SUCCINATE AND CILNIDIPINE IN BULK AND PHARMACEUTICAL DOSAGE FORM
Objective: Development and validation of stability indicating RP-HPLC method for the simultaneous estimation of Metoprolol succinate and Cilnidipine in bulk and pharmaceutical dosage form.Methods: The separation was carr...
CHARACTERIZATION, IN VITRO ANTIOXIDANT AND HEPATOPROTECTIVE ACTIVITY OF FUNGAL ENDOPHYTIC EXTRACTS OF ANDROGRAPHIS PANICULATA LEAVES IN CCL4 INDUCED HEPATOTOXICITY
Objective: To isolate and characterize the endophytic fungi from the leaves of Andrographis paniculata for free radical scavenging antioxidant and hepatoprotective activity against CCl4 induced hepatotoxicity Methods: T...
ENHANCEMENT OF ANTI-DIABETIC ACTIVITY OF 4-HYDROXYISOLEUCINE IN COMBINATION WITH NATURAL BIOAVAILABILITY ENHANCERS
Objective: This study investigates for the first time the antidiabetic activity of 4-hydroxy isoleucine (4-OH Ile) in combination with natural bioavailability enhancers, piperine and ginger oleoresin.Methods: Alloxan ind...
COMPARATIVE COMPOSITIONS AND ANTIBACTERIAL ACTIVITY OF THE ESSENTIAL OILS OF ANTHEMIS NOBILIS L. AND ANTHEMIS MIXTA L. (ASTERACEAE)
Objective: To evaluate the chemical composition of essential oils from aerial parts of Anthemis nobilis (An) and Anthemis mixta L (Am). and investigate their antibacterial property.Methods: The essential oils were isolat...